Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology... Show more
Industry Biotechnology
A.I.dvisor tells us that CLRPF and SBHMY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and SBHMY's prices will move in lockstep.
| Ticker / NAME | Correlation To CLRPF | 1D Price Change % | ||
|---|---|---|---|---|
| CLRPF | 100% | +0.32% | ||
| SBHMY - CLRPF | 24% Poorly correlated | N/A | ||
| BOLD - CLRPF | 23% Poorly correlated | +0.85% | ||
| AKBA - CLRPF | 21% Poorly correlated | +7.59% | ||
| DOSEF - CLRPF | 12% Poorly correlated | N/A | ||
| ACUT - CLRPF | 9% Poorly correlated | +5.20% | ||
More | ||||